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Background: Women having experienced several consecutive failing IVF cycles constitute a critical and particular
subset of patients, for which growing perception of irremediable failure, increasing costs and IVF treatment related
risks necessitate appropriate decision making when starting or not a new cycle. Predicting chances of LB might
constitute a useful tool for discussion between the patient and the clinician. Our essential objective was to dispose
of a simple and accurate prediction model for use in routine medical practice. The currently available predictive
models applicable to general populations cannot be considered as accurate enough for this purpose.
Methods: Patients with at least four consecutive Failing cycles (CFCs) were selected. We constructed a predictive
model of LB occurrence during the last cycle, by using a stepwise logistic regression, using all the baseline patient
characteristics and intermediate stage variables during the four first cycles.
Results: On as set of 151 patients, we identified five determinant predictors: the number of previous cycles with at
least one gestational sac (NGS), the mean number of good-quality embryos, age, male infertility (MI) aetiology and
basal FSH. Our model was characterized by a much higher discrimination as the existing models (C-statistics=0.76),
and an excellent calibration.
Conclusions: Couples having experienced multiple IVF failures need precise and appropriate information to decide
to resume or interrupt their fertility project. Our essential objective was to dispose of a simple and accurate
prediction model to allow a routine practice use. Our model is adapted to this purpose: It is very simple, combines
five easily collected variables in a short calculation; it is more accurate than existing models, with a fair
discrimination and a well calibrated prediction.
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Methods to predict chances of live birth (LB) have recently
attracted attention in assisted reproductive technology (ART)
research. As ART techniques have potential side effects and
are costly, before deciding on IVF (in vitro fertilisation), it
remains essential to estimate the chances of success. In par-
ticular, it has been suggested that ART should only be used* Correspondence: philippe.lehert@gmail.com
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reproduction in any medium, provided the orfor couples with a prognosis that significantly exceeds the
expected success rate in the absence of treatment [1].
The complex multi-factorial genesis of infertility prevents
clinicians from offering an accurate, reliable prognosis [2].
Hence, researchers have developed predictive models in
which the LB rate is predicted from the mix variables
(couple baseline demographic and clinical characteristics
and historical fertility data). However, these models cannot
be considered as an infallible panacea: Model-based predic-
tions can be biased, inaccurate or non-generalizable [3]. A
careful review of these models [4] revealed that only a few
can be considered as a guiding tool in making decisionstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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development population. However, these models lack dis-
crimination and calibration as to be used in routine me-
dical practice. Templeton’s model [5] for IVF, Hunault’s
model [6] for treatment-independent pregnancy and
Steures’ model [7] for IUI (intra-uterine insemination) were
considered as adequately validated. Templeton model is
the most widely used, despite a lack of accuracy, and poor
performances in external validation [8,9].
A first reason of the poor performances of models is the
considerable influence of the ART centre, expected to be
even more determinant than the patient mix [3]. The
centre effect combines several interrelated factors related
to centre-selected treatments and procedures and variable
skill levels. A second reason is that the models were li-
mited on historical data for which the available variables
were defined a priori by health authorities. A third reason
is the rapid evolution of techniques making a model obso-
lete some years after its development. To alleviate these
problems, Arvis et al. [10] have suggested modification of
Templeton according to a centre specific fitting approach
accounting for trend effect, and suggest to add new pre-
dictors (BMI, FSH and Smoking habits) in the model. In
using these changes, a much better discrimination and
calibration was observed, and found appropriate for rou-
tine practice use.
A last reason avoiding precision of the currently pro-
posed models is their generality, i.e. their ability to be
used for any centre and any type of patients. Among the
numerous possible sub-groups to consider, the set of
women having experienced several consecutive failed
cycles (CFCs, i.e. not resulting into a live birth) are of
particular interest. We concentrated on this subset for
three main reasons: a) For these patients, the decision to
start a new IVF cycle is particularly crucial, given the
previous failures, and the increasing perception of
doubtful Risk/Benefit ratio. b) In some countries, the
health insurance system compensates costs for a fixed
maximum number of cycles, which severely affects the
patient Cost/benefit ratio, when this number is
exceeded. c) Compared with patients entering a first
cycle, these patients are documented by many more po-
tential available predictors, in particular all the inter-
mediate and end-stage measurements of the previous
failing cycles (such as number of oocytes, embryos and
their quality). Thus using these measurements closer of
the studied endpoint should logically provide a much
higher precision of the prediction.
In France, the Health insurance reimburses four cycles
at the most. The occurrence of women with four CFCs
is not rare in our centre, and the concern and uncer-
tainty of these patients to embark or not a new cycle
appears such a crucial issue that we decided to perform
a specific research on this subgroup.Methods
Our site performs about 1600 IVF/ ICSI (intracytoplasmic
sperm injection) procedures and 1000 IUI cycles per year.
Since 2000, we record the characteristics of each cycle in
terms of the patient mix, treatments, biological and clinical
treatment outcomes. As the study was purely observational
and non-interventional, it was not necessary to declare it
to any Ethics Committee. Clinical characteristics for all
these patients were as follows: Pituitary desensitization was
treated with GnRH (gonadotropin-releasing hormone)
agonist or antagonist protocols with daily subcutaneous
administration of either 0.25 mg of cetrorelix (CetrotideW,
Merck Serono, Geneva, Switzerland), 0.25 mg of ganirelix
(OrgalutranW, Schering-Plough, Kenilworth NJ, USA) or 3
mg of long-acting cetrorelix (CetrotideW, Merck Serono).
The starting doses of recombinant FSH (follicle-stimulat-
ing hormone) and either follitropin beta, highly purified
gonadotropin, or human menopausal gonadotropin ranged
from 112.5 to 225 IU/day for patients with normal ovarian
reserve. hCG was administered once three follicles reached
a mean diameter ≥ 17 mm. Oocyte retrieval was per-
formed 35–36 hours after hCG injection by transvaginal,
ultrasound-guided follicular aspiration. For conventional
IVF or ICSI, fertilization was confirmed 18 hours after in-
semination. Embryos were classified according to their
morphological appearance using an embryo scoring system
(0 to 4 points) [11]. The luteal phase was supported by
intravaginal administration of 400 mg of micronized pro-
gesterone per day. Clinical pregnancy was confirmed when
ultrasonography performed approximately 5 weeks after
transfer demonstrated the presence of at least one gesta-
tional sac.Statistical analyses
We conducted a mixed linear model to assess the varia-
tion of the number of oocytes, embryos, good quality
embryos, and gestational sacs during the four CFCs. Our
primary endpoint was the occurrence of at least one LB.
Our study population consisted of patients with at least
four CFCs, and undertaking a new cycle, all of then per-
formed in our centre, without any other selection. A
logistic model was built with a stepwise strategy based
on minimization of the Akaike information criterion
(AIC [12]), considered as an appropriate trade-off bet-
ween determination and parsimony. The stepwise app-
roach was carried out during an expert meeting in
which the choice of predictors was discussed from both
clinical (literature search) and statistical (p-values and
AIC) standpoint. Given the expected small sample size,
exact tests were scheduled to assess the significance
[13]. The candidate predictors were specified a priori
and all the variables mentioned in previous models [4]
were available in our database.
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and expected (predicted) values of the observed response,
irrespective of prediction level) was assessed by Hosmer
and Lemeshow goodness of fit test [14]. Goodness of fit
was determined by the C-statistic (the area under the
ROC curve). Prognostic parameters are presented as the
odds ratio (OR) [95% confidence interval (CI)] relative to
the indicated reference category. For sensitivity purposes
and facilitating clinical interpretation, we compared the
logistic model, with an ordinary least squares OLS linear
model adapted for binary endpoints, where effects can be
interpreted as absolute risk difference per unit.
All statistical analyses were carried out with R software
(release 2.12.1).Results
Over the period 2001–2006, we identified 151 women
with at least five consecutive IVF cycles of which the
first four failed. Fifty-two (34%) of the 151 women were
under 35 years of age. Women under and over 35 years
were divided into subgroups and compared in terms of
patient mix variables and ART values (Table 1). The
main reasons for couple infertility were male infertility
(43%) and tubal abnormalities (30.5%). The mean number
of oocytes, embryos and good-quality embryos in the first
four cycles were all higher in women below 35 years than
in those aged 35 and over. For the 5th cycle, the LB pro-Table 1 Sample distribution and comparisons between
women <35 and ≥35 years of age





• Male infertility 30 57.7% 35 35.4% 65 43.0%
• Endometriosis 1 1.9% 6 6.1% 7 4.6%
• Unexplained 5 9.6% 14 14.1% 19 1..6%
• Tubal abnormalities 14 26.9% 32 32.3% 46 30.5%
• Viral risk 2 3.8% 12 12.1% 14 9.3%
Mean baseline
FSH (IU/L)
6.50 ± 2.79 7.11 ± 2.57 6.90 ± 2.65
Mean ± SD number
of oocytes
7.91 ± 3.40 6.79 ± 2.96 7.17 ± 3.15
Mean ± SD total
number of embryos
5.24 ± 2.57 4.76 ± 2.13 4.92 ± 2.30
Mean ± SD number
of good-quality
embryos
1.08 ± 0.77 0.84 ± 0.60 0.92 ± 0.67
Women with at least
one gestational sac (%)
37.5% 23.3% 28.2%
Women with at least
one foetal heart beat
(%)
37.0% 22.9% 27.8%
LB rate 36.5% 22.2% 27.2%
Values are given as numbers and percentages (%) or the mean ± SD. FSH:
follicle-stimulating hormone (iu/L). LB: live birth.portions were 36.5% and 22% in the two groups, respec-
tively, and 27% (range: 20%; 34%) for the whole sample.
Main predictive model
For each patient, the mean number of oocytes, embryos,
good-quality embryos remained constant over the 4
studied cycles (Mixed ANOVA, p<0.35 for all series).
Our stepwise strategy identified five significant predic-
tors (Table 2). The most determinant predictor was the
occurrence of at least one Gestational Sacs OGS observed
over the 4 last observed cycles, with an odds ratio (OR) of
3.09 (95% CI [1.39; 6.88]; p=0.005). The next identified
predictor was the mean number of good-quality embryos
over the four cycles (MQE) with another very positive
effect on LB (OR=2.42; 95% CI [1.32; 4.43]; p=0.004). Age
was found as third predictor (age-25 was used to define
the reference population) with a linearly decreasing effect
on LB (OR=0.87; 95% CI [0.78; 0.96]; p=0.008). Male infer-
tility aetiology was found with a positive effect on LB
(OR=3.86; 95% CI [1.09; 13.5]; p=0.005). Finally the binary
variable FSH10 (defined as 1 or 0 following that FSH was
less or exceeded 10 IU/L) was the last significant predictor
with a positive effect on LB (OR=4.22; 95% CI [1.26; 14.7];
p=0.019). The intercept value of the model was 0.044
(95% CI [0.006; 0.392]; p=0.004), provides an estimate of
4.4% of success rates for a standard population defined
such that all the predictors are fixed to 0, thus women
aged of 25 years, with FSH>10, with any aetiology except
male infertility, without any cycle with at least one gesta-
tional sac and no good quality embryo.
All the other variables were found as not determinant:
the number of embryos transferred, secondary vs. primary
infertility, GnRH down-regulation agonist or antagonist,
FSH supplementation, stimulation duration (mean value
over all cycles and the separate values for each cycle),
hCG supplementation, hCG dosage, mean total number
of oocytes and mean total number of embryos.
The model discrimination was studied with a ROC
curve (C-statistic =75.4; 95% CI [70.1; 80.8]). The cali-
bration was examined by calculating the difference bet-
ween the observed and predicted probabilities within
6 categories of increasingly high estimated probabilities.
Hosmer-Lemeshow’s test did not reject the hypothesis of
goodness of fit between the observed and predicted
values (p=0.651).
For sensitivity purpose, we conducted an alternative
OLS (ordinary least square) model which derived very
similar results (Table 2). Compared with the logistic
model, this expression was characterized by a loss of dis-
crimination (C=72.2; 95% CI [66.1, 77.3]).
Discussion
Predicting Live Birth chances for a couple consulting for
sub-fertility is nowadays considered as an important step
Table 2 The main predictive data from the logistic regression model
Effects Logistic Model Linear Simplified Model
OR 95% CI P Incr 95% CI P
Intercept 0.044 0.006; 0.392 0.004 0.045 0; 0.350 0.047
Women age 0.868 0.782; 0.964 0.008 −0.023 −0.039; −0.006 0.009
FSH < 10 IU/L 4.222 1.267; 14.077 0.019 0.200 0.039; 0.361 0.016
Male Infertility Etiology (MI) 3.862 1.097; 13.595 0.035 0.172 0.011; 0.334 0.038
occurrence of at least one GS (OGS) 3.099 1.395; 6.884 0.005 0.174 0.047; 0.302 0.008
Mean number of GQE (MQE) 2.422 1.322; 4.437 0.004 0.168 0.064; 0.263 0.003
Proportion of variability due to covariates R2=0.2955; ROC curve AUC (C) = 0.76 (95% CI [0.71–0.81]) and the simplified model (from an ordinary least squares
procedure suited to binary data). OR: odds ratio; CI: confidence interval. Logistic model coefficients can be assimilated to OR, and linear model coefficients to
incremental values (Incr). For interpreting OR and Incr, age, number of cycles with at least one sac, and mean number are continuous values, while FSH<10 IU/L
and Male infertility are binary values.
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groups of patients, the a priori knowledge of LB probability
seems more important to know: This is particularly the
case when a couple has experienced several failed cycles,
resulting to a growing perceived concern of irremediable
failure, increasing in the same time IVF related side effects
and costs. The final decision to start a new cycle must be
discussed between the clinician and the couple. In this
context, a prediction model based on historical experience
of this couple constitutes an appropriate quantitative and
objective measurement tool. This model must obviously
be accurate, thus we tried to optimize its precision in
restraining our population to patients with multiple fai-
lures, specific to our centre in particular.
Clinical findings and comparison with previous models
Our results may usefully be compared with those from
other models that are applicable to the general population.
Age remains a determinant factor and was associated with
a linear decrease in fertility. Due to the expected low pro-
portion of young (<30 years) women in this category, the
non-linear effect of age found in other models [5,10] was
not confirmed. Male infertility was already identified as the
infertility cause associated with better outcomes opposed
to tubal problems, which has a particularly negative prog-
nosis [9,15]. High basal FSH values were recently consi-
dered as a prognostic factor for a poor ovarian response
[10,16], and the same cut-off critical value of 10 IU/L was
confirmed.
However, the most important predictors were OGS
(one gestational sac) and MQE. MQE was already sug-
gested in previous researches [17], it constitutes an in-
trinsic, woman-specific quality characteristic of oocyte
production, confirmed by our analysis demonstrating a
constant value of the number of quality embryos across
cycles. OGS may additionally be related to independent
paternal effects and implantation quality [18] for which
other measurements (endometrial thickness, in particu-
lar) were not available. OGS takes into account the
oocyte quality, the quality of the partner’s genetic in-formation and the endometrial receptivity [19]. Lastly,
given that the gestational sac is and end-stage in the ART
process, its high determination on LB was expected.
Model performance
Fixing all the predictors to zero in our model (Table 2)
characterizes a population of 25 years old, FSH>10 IU/L,
any aetiology except male infertility, and no good quality
embryo or gestational sac obtained during the last
cycles. Except for age, this reference population corre-
sponds to the worst case or most unfavourable case in
terms of LB success. The intercept value of our model
provides a very low estimate of LB of 4.4%, and this
value is even expected to decrease with increasing age.
However, it may considerably increase depending on the
values of the four predictors (OGS, MQE, FSH10 and
MI). As a corollary, if at least one of these conditions is
not fulfilled, the predicted LB rate is close of 0%, thus
the interest of conducting IVF is very limited, at any age.
Our linear model (Table 2) allows to apprehend the
high variation of prediction: Compared with the refer-
ence population, a value of FSH<10 contributes to an LB
increase of 20%, whereas, each of the conditions MI,
OGS and MQE increments LB probability of around
17%, thus a couple characterized by the four condi-
tions may be predicted with a probability as high as
20+3*17=74%. Whereas the reference population is
characterized by a virtually null probability of live
birth, depending on the four predictors may dramatically
make vary LB. In particular, couples characterized by at least
one of the positive predictors (MI, OGS, MQE, FSH10) cor-
respond to LB predictions of at least 17%, a value not far
from observed LB rates in normal populations.
These results highlight the importance of individual
prediction: Based on this sample, we found an LB rate of
27% (range: 20%; 34%), which seems to show that even
after four CFCs, the LB probability remains non-neg-
ligible. However, this value is extremely varying among
patients, depending on a small number of variables in-
cluded in our model.
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A model is considered to have poor, fair or good perfor-
mance levels if the C statistic lies between 0.5 and 0.7, 0.7
and 0.8 or 0.8 and 0.9, respectively [20]. Our C-statistic of
0.76 (95% CI [0.71; 0.81]) shows that performance was fair
and markedly better that the poor discrimination exhi-
bited by Templeton model, (0.56 < C < 0.63) (See Figure 1).
A recent attempt to model LB in a single centre by using
embryo quality as the main predictor [21] resulted in simi-
larly high discrimination (C=0.77). We attribute this im-
provement to the strong predictive value of OGS and
MQE, parameters which are biologically and chronologic-
ally closer to the endpoint (LB) than the baseline para-
meters used in Templeton model.
External validation, generalizability and implication for
practice
Our objective was to develop a prediction model for
patients characterized by multiple CFCs. As we initially
conjectured it, this model was found more determinant
than models set up on general population, and thus it is
appropriate for use in routine medical practice. This model
is very simple, only requires 5 values easy to retrieve, and a
simplified calculation can be easily derived from our linear
model.
This model was developed in one centre, the question
as to which extent can such results be useful for other
centre needs in principle an external validation. Our
results might probably constitute a good approximation.
Given the high between-centre variability observed in
the literature, a centre-specific model is probably the
simplest, most powerful and highly feasible solution
[10]. Ideally, the model can be re-fitted to the specificFigure 1 The ROC curves associated with the primary model.
(C-statistic: 0.76, [0.71–0.81]) and the simplified model (C- statistic:
0.66, [0.61–0.72]).data of a centre in particular. Fitting a logistic regression
is an easy task, including complementary techniques to
preserve stability and reduce the overfit of the model.
However, the number of patients with multiple CFCs is
not so common, and a sufficient sample size will rarely
be reached except for large centres. Moreover, inter-
centre coordination should be necessary for the very
common case in which patients are switching to other
centres after some negative experience.
In spite of this possibility, we argue that our model
can be considered as a good approximation: The invari-
ance of the Templeton model was recently demonstrated
from adapted external validations [10]: The coefficients
mix-related remained comparable among centres, across
various cultures, countries and types of hospitals, only
the intercept value was found much different across
centres, in estimating the centre performance (mean
LB rate). Our model uses essentially the same variables
thus we argue that the coefficients of these variables
must remain stable across centres. The intercept of the
model was very small and corresponds to LB rate in the
most unfavourable populations, this value should remain
very low, irrespective of centres. In total, as the intercept
is negligible, our model should constitute a fair approxi-
mation, when applied to other centres. Finally, our linear
model, although slightly less accurate allows a very easy
calculation of LB: Starting from a virtually null probabi-
lity of LB, adding 20% when FSH<10, adding 17% for
each of the three positive conditions (MQE, OGS, NI)
and subtracting 2% for each year in excess of 30. As an
example, LB probability for a 40 years women of
observed with FSH<10 and a mean number of QE for
every cycle should be 20+17-2*(40–30)=17%.
Study limitations
Our dataset was not a random dataset and not all the
patients with at least four CFCs were treated, a part of
these couples dropped out and renounced to their ferti-
lity project. It is probable that more favourable prognosis
were treated, thus our estimate compared with the strict
population should be over-estimated on a strict Intent to
Treat basis. In that sense, our research has not the
objective to determine an estimate of LB rate in the
population of couples with multiple CFCs. Malizia et al.
[22] clearly underlined the difference between patient
returning to IVF, and those interrupting their project, in
showing the poorer prognosis of the latter group. As a
consequence, for optimistic and conservative estimates,
we calculated in censoring non-returning patients or as-
similating them as failures, respectively. Our objective
was to predict LB chances for patients returning in our
centre to evoke a new possible IVF cycle, thus a correc-
tion for non-returning patients is not necessary. How-
ever, the proportion of LB found in our study cannot be
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ning patients.
Another study limitation related to our relatively small
sample size. However, the number of patients with 4
CFCs is not so common, and requires a large recruit-
ment to remain in one centre. Moreover, when facing
failures, many couples switch to other centres, which
makes their follow-up very difficult to maintain. We in-
tend to improve our model in extending results with a
collaborative multicentre regional study, in federating
neighbour sites to easily dealing with between-centres
patients’ switches. We also plan to use an adaptive tech-
nique to account for new patients and add variables that
were not documented when we started the project. On
the basis of our current C-statistic of 0.76, first new cal-
culations should allow an increase of model discrimi-
nation until C=0.8, thus provide an even more precise
prediction.
Conclusions
Women with multiple failing cycles constitute a critical
and particular subset, for which growing perception of
irremediable failure, increasing costs and drug-risks ne-
cessitate a precise measurement tool of success, before
starting a new cycle. Our essential objective was to dis-
pose in routine medical practice of a simple and accu-
rate prediction model, so far not available from previous
researches. In taking advantage of more discriminatory
variables such as the number of gestational sacs or good
quality embryos, we provide an easy rule enabling a sim-
ple calculation of LB probability, combining five simple
individual characteristics, presumably considered as a
good approximation to any centre in particular.
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